Cargando…
Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022
We used data of 32,542 prospective cohort study participants who previously received primary and one or two monovalent booster COVID-19 vaccinations. Between 26 September and 19 December 2022, relative effectiveness of bivalent original/Omicron BA.1 vaccination against self-reported Omicron SARS-CoV...
Autores principales: | Huiberts, Anne J, de Gier, Brechje, Hoeve, Christina E, de Melker, Hester E, Hahné, Susan JM, den Hartog, Gerco, van de Wijgert, Janneke HHM, van den Hof, Susan, Knol, Mirjam J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936593/ https://www.ncbi.nlm.nih.gov/pubmed/36795500 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.7.2300087 |
Ejemplares similares
-
Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study
por: Huiberts, Anne J., et al.
Publicado: (2023) -
Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
por: de Gier, Brechje, et al.
Publicado: (2023) -
Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023) -
Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Knol, Mirjam J, et al.
Publicado: (2022) -
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022
por: Andeweg, Stijn P, et al.
Publicado: (2023)